Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +873.6% | +262.3% | 2 / 3 | -31.4% | +12.10 pp | +7.13 pp | +14.6% | 0.31 | 4.70 | 125 | −31,4% | 9,6 | +873,6% | 4.70 | 4.85 | −3,1% |
| Pts | 12 | 12 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 3.400 (close price on 2026-10-16)EPS (TTM): 723,6
Financial charts
1.Revenue & growth
VND bn125Q3/26
1.Revenue & growth
VND bn125Q3/26
2.Profit & growth
VND bn9,59Q3/26
3.Profit mix (Penman)
VND bn18,3Q3/26
4.Margins & cost structure
%4.1%Q3/26
5.Returns & cash cycle
% · days13.8%Q3/26
6.Earnings quality & cash
VND bn19,7Q3/26
7.Asset structure
VND bn344Q3/26
8.Funding & debt health
VND bn · times344Q3/26
9.Revenue backlog
VND bn0,41Q3/26
10.Valuation
times · %4,7×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %480Q3/26
Adjusted EPS growth, latest quarter
874%
Average adjusted EPS growth, 3 quarters
262%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26